NL-OMON21903招募中不适用
The role of anticipation in nocebo effects on pain
eiden University, Leiden, the Netherlands0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adults ages 18-35
- •Strong understanding of written and spoken English
- •Normal or corrected to normal vision
排除标准
- •1. Ever having experienced serious medical or psychiatric conditions (e.g., heart or lung disease, panic attacks, alcohol addiction, clinical depression), including any present conditions thought to increase the risk of a serious COVID-19 infection (diabetes, severe obesity, HIV, severe kidney or liver diseases) and the presence of any condition or treatment that causes a reduced resistance to infections (autoimmune disorders, blood disorders, organ or stem cell transplant recipients, people without spleens).
- •2. Currently experiencing or having experienced in the last 48 hours any symptoms of COVID-19 (cough, sore throat, fever, trouble breathing, muscular pain, pain behind the eyes, excessive fatigue, diarrhoea, loss of sense of smell or taste).
- •3. Having tested positive for COVID-19 fewer than 7 days ago.
- •4. After testing positive for COVID-19 more than 7 days ago, not being symptom free for at least 48 hours.
- •5. Having a housemate/partner test positive for COVID-19 (or an untested but suspected COVID-19 infection) in the past month.
- •6. Ever having experienced chronic pain complaints (pain for more than 6 months).
- •7. Ever having experienced persisting painful health problems in the last 6 months.
- •8. Ever having experienced acute physical pain (more than 1 on the 0-10-point pain Numeric Rating Scale (NRS); e.g., mild headache), on the day of testing.
- •9. Having used pain medication or recreational drugs in the 24 hours prior to testing.
- •10. Having consumed more than 3 caffeinated drinks (coffee, tea, energy drinks, etc.) on the day of testing, any alcohol the day of testing, or more than 3 units of alcohol in the 24 hours before testing.
- •11. (Intended) pregnancy or breastfeeding.
- •12. Having recent injuries to the head, wrists or arms on the day of testing.
- •13. Previous participation in this or similar studies (e.g., using thermal pain).
- •14. On the day of testing: not being able to sufficiently distinguish between the different temperatures during calibrations and nocebo acquisition, or not reporting a pain of at least 6 (0-10 pain NRS scale) with the highest temperature used during calibrations.
研究者
相似试验
已完成
不适用
The Role of Learning in Nocebo HyperalgesiaNocebo EffectsHyperalgesiaChronic PainPain SyndromeNCT03793790Leiden University Medical Center140
已完成
不适用
Investigation of the predictability of pain after implantation of a total hip endoprosthesis using the nociceptive flexion reflex and the pupillary dilatation reflexPostoperative painR52.9Pain, unspecifiedDRKS00000665Charité - Universitätsmedizin Berlin110
已完成
不适用
Pain-related Fear as a Facilitator of Nocebo HyperalgesiaHyperalgesiaChronic Pain SyndromeChronic Pain, PsychogenicFear of PainNCT04197154Leiden University Medical Center72
已完成
不适用
Effects of expectations on pain perception and learning in fibromyalgia patientsfibromyalgiaNL-OMON45539niversiteit Leiden60
已完成
不适用
Electrophysiological Correlates of Nocebo Effects on PainChronic Pain SyndromeChronic Pain, PsychogenicChronic PainHyperalgesiaNCT04199858Leiden University Medical Center36